Selected article for: "adaptive innate and interferon type"
Author: Xie, Bing; Zhang, Jiancheng; Li, Yuwen; Yuan, Shiying; Shang, You
Title: COVID-19: Imbalanced Immune Responses and Potential Immunotherapies
  • Cord-id: fmg6d81u
  • Document date: 2021_1_29
    • ID: fmg6d81u
    Snippet: The ongoing pandemic coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is rapidly spreading and has resulted in grievous morbidity and mortality worldwide. Despite the high infectiousness of SARS-CoV-2, the majority of infected individuals are asymptomatic or have mild symptoms and could eventually recover as a result of their balanced immune function. On the contrary, immuno-compromised patients are prone to progress into severe or critic
    Document: The ongoing pandemic coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is rapidly spreading and has resulted in grievous morbidity and mortality worldwide. Despite the high infectiousness of SARS-CoV-2, the majority of infected individuals are asymptomatic or have mild symptoms and could eventually recover as a result of their balanced immune function. On the contrary, immuno-compromised patients are prone to progress into severe or critical types underpinned by the entanglement of an overexuberant proinflammatory response and injured immune function. Therefore, well-coordinated innate and adaptive immune systems are pivotal to viral eradication and tissue repair. An in-depth understanding of the immunological processes underlying COVID-19 could facilitate rapidly identifying and choosing optimal immunotherapy for patients with severe SARS-CoV-2 infection. In this review, based on current immunological evidence, we describe potential immune mechanisms and discuss promising immunotherapies for COVID-19, including IL-6R blockades, convalescent plasma, intravenous gamma globulin, thymosin alpha1, corticosteroids, and type-I interferon, and recent advances in the development of COVID-19 vaccines.

    Search related documents:
    Co phrase search for related documents
    • accessory protein and acid inducible gene: 1
    • accessory protein and activation dependent: 1, 2, 3
    • accessory protein and acute ards respiratory distress syndrome: 1
    • accessory protein and acute infection: 1, 2, 3, 4, 5, 6
    • accessory protein and acute infection response: 1
    • accessory protein and low expression: 1, 2
    • accessory protein and lung damage: 1
    • accessory protein and lung epithelial proliferation: 1
    • accessory protein and macrophage inflammatory: 1
    • accessory protein and macrophage monocyte: 1
    • acute ards respiratory distress syndrome and adaptive cell: 1, 2
    • acute ards respiratory distress syndrome and adaptive immune cell: 1, 2
    • acute ards respiratory distress syndrome and adaptive immune cell innate: 1, 2
    • acute ards respiratory distress syndrome and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acute ards respiratory distress syndrome and adaptive immune system: 1, 2, 3, 4
    • acute ards respiratory distress syndrome and long duration: 1, 2, 3, 4
    • acute ards respiratory distress syndrome and longitudinal study: 1, 2, 3, 4, 5
    • acute ards respiratory distress syndrome and low concentration: 1
    • acute ards respiratory distress syndrome and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37